Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azam Majidi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Public Health Nutrition|April 29, 2024
Inflammatory potential of diet and mortality in Australian adultsAzam Majidi, Maria Celia B Hughes, Imogen K Webb, et al.
Journal of the National Cancer Institute|February 6, 2023
Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) StudyAzam Majidi, Renhua Na, Susan J Jordan, et al.
Cancer Epidemiology|November 21, 2025
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) studyAzam Majidi, Renhua Na, Susan J Jordan, et al.
Medicine|February 18, 2016
Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional AnalysisBatoul Ahmadi, Masoomeh Alimohammadian, Mehdi Yaseri, et al.
International Journal of Health Policy and Management|May 31, 2016
Priority Setting for Improvement of Cervical Cancer Prevention in IranAzam Majidi, Reza Ghiasvand, Maryam Hadji, et al.
BMJ Open|May 12, 2017
Multimorbidity as an important issue among women: results of a gender difference investigation in a large population-based cross-sectional study in West AsiaMasoomeh Alimohammadian, Azam Majidi, Mehdi Yaseri, et al.
Journal of the National Cancer Institute|June 26, 2026
Pre-diagnosis thyroid biomarkers and breast cancer survival: evidence from a European prospective cohort studyCarlota Castro-Espin, Mathilde His, Agnès Fournier, et al.
Journal of the National Cancer Institute|August 14, 2025
Thyroid hormones and epithelial ovarian cancer risk and survival: results from the EPIC studyAzam Majidi, Sabina Rinaldi, Carine Biessy, et al.
The Lancet. Oncology|December 2, 2024
Carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimusVincent J Cogliano, Emanuela Corsini, Agnès Fournier, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Public Health Nutrition|April 29, 2024
Inflammatory potential of diet and mortality in Australian adultsAzam Majidi, Maria Celia B Hughes, Imogen K Webb, et al.
Journal of the National Cancer Institute|February 6, 2023
Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) StudyAzam Majidi, Renhua Na, Susan J Jordan, et al.
Cancer Epidemiology|November 21, 2025
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) studyAzam Majidi, Renhua Na, Susan J Jordan, et al.
Medicine|February 18, 2016
Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional AnalysisBatoul Ahmadi, Masoomeh Alimohammadian, Mehdi Yaseri, et al.
International Journal of Health Policy and Management|May 31, 2016
Priority Setting for Improvement of Cervical Cancer Prevention in IranAzam Majidi, Reza Ghiasvand, Maryam Hadji, et al.
BMJ Open|May 12, 2017
Multimorbidity as an important issue among women: results of a gender difference investigation in a large population-based cross-sectional study in West AsiaMasoomeh Alimohammadian, Azam Majidi, Mehdi Yaseri, et al.
Journal of the National Cancer Institute|June 26, 2026
Pre-diagnosis thyroid biomarkers and breast cancer survival: evidence from a European prospective cohort studyCarlota Castro-Espin, Mathilde His, Agnès Fournier, et al.
Journal of the National Cancer Institute|August 14, 2025
Thyroid hormones and epithelial ovarian cancer risk and survival: results from the EPIC studyAzam Majidi, Sabina Rinaldi, Carine Biessy, et al.
The Lancet. Oncology|December 2, 2024
Carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimusVincent J Cogliano, Emanuela Corsini, Agnès Fournier, et al.
Pageof 2